Unjha Formulations Q4 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
23.44
0.15 (0.64%)
0.15 (0.64%)Volume1.55 K
Updated: Mon 16 Feb, 2026 | 10:46:16
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2.73 | 4.20 | -23.09% | 4.39 | -37.88% |
| Depreciation/ Amortization | 0.03 | 0.04 | 34.50% | 0.02 | 36.28% |
| Operating Income | -0.36 | 0.21 | 0.00% | 0.04 | 0.00% |
| Net Income | -0.40 | 0.24 | 0.00% | -0.18 | 131.20% |
| Net Income Before Taxes | -0.29 | 0.24 | 0.00% | 0.00 | 26136.36% |
| Other Operating Expenses Total | 0.12 | 0.45 | -64.94% | 0.39 | -68.29% |
| Total Revenue | 2.37 | 4.41 | -37.13% | 4.43 | -46.57% |
| Selling/ General/ Admin Expenses Total | 0.36 | 0.32 | 85.79% | 0.14 | 157.74% |
| Diluted Normalized EPS | -0.91 | 0.53 | 0.00% | -0.39 | 132.69% |